Tambet Teesalu is an internationally recognized leader in using in vivo peptide phage display to develop organ- and disease-specific homing peptides and to characterize vascular heterogeneity (“vascular ZIP codes”). Metrics: >EUR 8M grant funding, >100 publications, multiple patents/pt.applications.